Fatal anaphylaxis due to alpha-gal syndrome after initial cetuximab administration: The first forensic case report.
Sign Up to like & getrecommendations! Published in 2021 at "Legal medicine"
DOI: 10.1016/j.legalmed.2021.101878
Abstract: Cetuximab is mainly used for the treatment of advanced and metastatic colorectal cancer. Owing to the oligosaccharide galactose-α-1,3-galactose (α-gal) in its heavy chain, cetuximab can induce severe IgE-dependent anaphylaxis. α-Gal is also the antigen responsible… read more here.
Keywords: medicine; administration; cetuximab; gal syndrome ... See more keywords